Search research articles
Contact Us
Filters
Showing results (171-180 of 4,048) with videos related to
Page
of 405
Sort By:
Nature Biotechnology
|
May 7, 2005
Earlier stage biotechs attract partners
Mark Ratner
Bio/Technology (Nature Publishing Company)
|
January 1, 1991
When microheterogeneity matters
M Ratner
Skinmed
|
December 16, 2003
Dermatofibrosarcoma protuberans: surgical treatment options
Désirée Ratner
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|
December 29, 1999
Taking our case public
I Ratner
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 30, 2001
Commentary on malignant eccrine spiradenoma
D Ratner
Nature Medicine
|
March 9, 2011
Fearful of Avastin's fate, Genentech asks for unusual hearing
Mark Ratner
Nature Biotechnology
|
April 12, 2011
Genzyme-Sanofi buy out is second largest biotech deal ever
Mark Ratner
Blood
|
February 12, 2011
JAK blockade and HTLV
Lee Ratner
Nature Biotechnology
|
October 15, 2010
Genzyme resumes shipping as Sanofi-aventis hovers
Mark Ratner
Nature Medicine
|
June 8, 2012
Straight talk with...Joseph Schwartz
Mark Ratner
Page
of 405
Search research articles
Search
Showing results (171-180 of 4,048) with videos related to
Sort By:
Page
of 405
Nature Biotechnology
|
May 7, 2005
Earlier stage biotechs attract partners
Mark Ratner
Bio/Technology (Nature Publishing Company)
|
January 1, 1991
When microheterogeneity matters
M Ratner
Skinmed
|
December 16, 2003
Dermatofibrosarcoma protuberans: surgical treatment options
Désirée Ratner
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|
December 29, 1999
Taking our case public
I Ratner
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 30, 2001
Commentary on malignant eccrine spiradenoma
D Ratner
Nature Medicine
|
March 9, 2011
Fearful of Avastin's fate, Genentech asks for unusual hearing
Mark Ratner
Nature Biotechnology
|
April 12, 2011
Genzyme-Sanofi buy out is second largest biotech deal ever
Mark Ratner
Blood
|
February 12, 2011
JAK blockade and HTLV
Lee Ratner
Nature Biotechnology
|
October 15, 2010
Genzyme resumes shipping as Sanofi-aventis hovers
Mark Ratner
Nature Medicine
|
June 8, 2012
Straight talk with...Joseph Schwartz
Mark Ratner
Page
of 405